Assenagon Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-471,134
Closed -$47.8M 1145
2025
Q4
$47.8M Buy
+471,134
New +$37.8M 0.07% 221
2025
Q2
Sell
-8,645
Closed -$374K 1179
2025
Q1
$374K Sell
8,645
-14,156
-62% -$717K ﹤0.01% 1053
2024
Q4
$1.28M Buy
22,801
+12,912
+131% +$804K ﹤0.01% 1053
2024
Q3
$674K Sell
9,889
-11,410
-54% -$644K ﹤0.01% 1195
2024
Q2
$900K Buy
21,299
+13,688
+180% +$753K ﹤0.01% 1118
2024
Q1
$526K Sell
7,611
-1,167
-13% -$73.8K ﹤0.01% 1200
2023
Q4
$649K Buy
8,778
+2,358
+37% +$155K ﹤0.01% 1197
2023
Q3
$438K Buy
6,420
+1,864
+41% +$158K ﹤0.01% 1220
2023
Q2
$428K Sell
4,556
-73,666
-94% -$5.75M ﹤0.01% 1155
2023
Q1
$5.3M Buy
78,222
+58,126
+289% +$3.74M 0.02% 564
2022
Q4
$995K Buy
20,096
+1,334
+7% +$54.5K ﹤0.01% 1039
2022
Q3
$610K Buy
18,762
+1,990
+12% +$82K ﹤0.01% 1067
2022
Q2
$661K Buy
+16,772
New +$897K ﹤0.01% 1171
2021
Q1
Sell
-43,795
Closed -$5.8M 1229
2020
Q4
$5.8M Buy
+43,795
New +$5.3M 0.03% 333
2020
Q2
Sell
-8,866
Closed -$514K 1147
2020
Q1
$514K Buy
+8,866
New +$720K ﹤0.01% 635
2018
Q3
Sell
-17,530
Closed -$1.05M 786
2018
Q2
$1.05M Buy
+17,530
New +$943K 0.01% 376

Other funds holding EXAS

Assenagon Asset Management's EXAS Position: Q1 2026 in Review

Assenagon Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 471,134 shares — an estimated $47.8M sold.

Assenagon Asset Management first reported a position in EXAS in Q2 2018 and held it in 16 quarters. The position peaked at $47.8M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Assenagon Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 471,134 Exact Sciences shares in Q1 2026, an estimated $47.8M.
  • Assenagon Asset Management first reported a position in Exact Sciences in Q2 2018 and held it in 16 quarters.
  • Assenagon Asset Management's Exact Sciences position peaked at $47.8M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.